Title |
The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation
|
---|---|
Published in |
Archives of Pharmacal Research, November 2014
|
DOI | 10.1007/s12272-014-0519-x |
Pubmed ID | |
Authors |
Dong Young Kim |
Abstract |
APOBEC3G is a cellular antiviral protein that restricts retroviral infection. In non-permissive cells infected by Vif-deficient HIV-1, the protein mediates the hypermutation of viral DNA through the enzymatic activity of cytidine deaminase. To counteract the antiviral activity of APOBEC3G, an accessory protein of HIV-1, Vif, forms ubiquitin E3 ligase through assembly with CUL5-RBX2, ELOB-ELOC and CBFβ. Subsequently, Vif recruits APOBEC3G to the complex as a substrate adaptor of ubiquitin E3 ligase and induces poly-ubiquitination of APOBEC3G for its proteasomal degradation (Fig. 1). This review briefly summarizes current understanding of protein-protein interaction between Vif and host factors required for APOBEC3 degradation, based on high resolution structures of APOBEC3 proteins and Vif-CUL5NTD-ELOBC-CBFβ complex. Fig. 1 A schematic model of assembly of Vif ubiquitin E3 ligase and subsequent APOBEC3 degradation. HIV-1 Vif hijacks cellular E3 ligase components containing CUL5, RBX2, ELOB, ELOC and CBFβ, to poly-ubiquitinate antiviral cellular factors, APOBEC3 proteins. Poly-ubiquitinated APOBEC3 proteins are targeted for proteasomal degradation. Ubiquitin is labeled as Ub. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 6% |
Unknown | 17 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 22% |
Researcher | 4 | 22% |
Student > Master | 4 | 22% |
Student > Bachelor | 2 | 11% |
Other | 1 | 6% |
Other | 1 | 6% |
Unknown | 2 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 8 | 44% |
Agricultural and Biological Sciences | 4 | 22% |
Medicine and Dentistry | 2 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Chemistry | 1 | 6% |
Other | 1 | 6% |
Unknown | 1 | 6% |